Janet Harris-Hicks, MD
Urogynecology and Reconstructive Pelvic Surgery · Myrtle Beach, SCNPI 1225125669
Payments from drug & device makers
Across 555 payments — averaging $1221.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$363K
- Coloplast$230K
- AbbVie$32K
- Boston Scientific$22K
- Sumitomo Pharma America, Inc.$12K
- Intuitive Surgical$11K
- plus $7K from 17 others
Across 33 payments — averaging $5045.25 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Coloplast$166K
- Medtronic$315
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 107 | $363,430 |
| Coloplast | 284 | $229,956 |
| AbbVie(2 entities) | 32 | $31,692 |
| Boston Scientific | 4 | $22,197 |
| Sumitomo Pharma America, Inc. | 12 | $12,088 |
| Intuitive Surgical | 28 | $11,353 |
| Axonics, Inc. | 27 | $3,357 |
| Escala Medical Inc. | 3 | $1,011 |
| Minze Health, Inc | 2 | $903 |
| Astellas Pharma US Inc | 27 | $732 |
| Teleflex LLC | 3 | $384 |
| Femselect Inc. | 2 | $123 |
| Pfizer | 6 | $100 |
| Neuraxis, Inc. | 1 | $81 |
| Laborie Medical Technologies Corp. | 3 | $73 |
| Novo Nordisk | 3 | $56 |
| Therapeuticsmd, Inc. | 2 | $42 |
| Ascend Therapeutics US, LLC | 2 | $35 |
| AMAG Pharmaceuticals, Inc. | 2 | $31 |
| Urovant Sciences Inc | 2 | $30 |
| Myovant Sciences Inc. | 1 | $25 |
| Ambu Inc. | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $15 |
How this compares
Too few urogynecology and reconstructive pelvic surgery providers in South Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other urogynecology and reconstructive pelvic surgery in Myrtle Beach
- Thomas GiudiceWest Columbia$418K
- Eric RovnerCharleston$316K
- Gerald TaylorCharleston$28K
- Jessica RuebWest Columbia$12K
- Steven SwiftCharleston$10K
- Rebecca RinkoGreenville$9K
- Ronald GlinskiFlorence$8K
- Thomas WheelerSpartanburg$7K
- Collin McKenzieWest Columbia$6K
- Johnnie WrightColumbia$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.